Tumor Acidity-Triggered Bioorthogonal Reactions for Biomedical Applications
Xiajian Liu1, Ihsan Ullah1, Youyong Yuan1,2
1School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou, 511442, China.
Chembiochem : a European Journal of Chemical Biology
|June 28, 2024
Summary
Tumor acidity plays a key role in cancer. Bioorthogonal reactions triggered by tumor acidity offer a promising strategy for cancer diagnosis and therapy, with ongoing research addressing clinical challenges.
Area of Science:
- Biomedical Engineering
- Oncology
- Chemical Biology
Background:
- Cancer poses a significant global health threat.
- Tumor acidity is increasingly recognized for its role in cancer progression and treatment resistance.
- Bioorthogonal reactions offer precise molecular tools for biological applications due to their specificity and efficiency.
Purpose of the Study:
- To elucidate the concept and strategies of tumor acidity-triggered bioorthogonal reactions.
- To review the advancements in biomedical applications of these reactions.
- To discuss clinical challenges and future directions in this field.
Main Methods:
- Literature review of tumor acidity and bioorthogonal reaction applications.
- Analysis of strategies for triggering bioorthogonal reactions using tumor microenvironment acidity.
- Synthesis of current research on diagnostic and therapeutic uses.
Main Results:
- Tumor acidity-triggered bioorthogonal reactions represent an emerging and effective strategy in oncology.
- These reactions show significant potential in enhancing tumor diagnosis and therapeutic outcomes.
- Key advantages include biocompatibility, rapid kinetics, and high specificity.
Conclusions:
- Bioorthogonal reactions modulated by tumor acidity hold great promise for innovative cancer diagnostics and therapeutics.
- Further research is needed to overcome clinical hurdles and fully realize their potential.
- This approach offers a novel avenue for targeted cancer treatment strategies.
